Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrous Oxide in Resistant Depression in Elderly Subjects
2019-004984-31Phase 3Active
- Sponsor
- CHRU Tours
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nitrous oxide in major depressive disorder (MDD) (2 arms), sponsored by CHRU Tours. Primary endpoint: Change in MADRS Depression Severity Scale. Started Feb 2021; status: active.
02
Drugs
nitrous oxide
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2019-004984-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004984-31.